STOCKWATCH
·
Electromedical & Electrotherapeutic Apparatus
Quarterly ResultApr 21, 2026, 05:32 PM

Neuraxis Q1 2026 Preliminary Net Sales Up 78% to $1.6M

AI Summary

Neuraxis, Inc. announced preliminary unaudited financial results for the first quarter ended March 31, 2026. The company expects net sales to be approximately $1.6 million, a significant increase from $0.9 million in the prior year's quarter. Cash and cash equivalents are estimated at $7.1 million as of quarter-end, with an expected gross profit of $1.4 million and an operating loss of $1.7 million. These figures are preliminary and subject to change as the company finalizes its financial statements.

Key Highlights

  • Preliminary Q1 2026 net sales expected at $1.6 million, up 78% year-over-year.
  • Cash and cash equivalents approximately $7.1 million as of March 31, 2026.
  • Preliminary Q1 2026 gross profit expected at $1.4 million.
  • Preliminary Q1 2026 operating loss expected at $1.7 million.
NRXS
Electromedical & Electrotherapeutic Apparatus
Neuraxis, INC

Price Impact